NME1 and cancer: Decreased NME1 protein in tumor samples is correlated with characteristics of aggressive cancer, such as poor clinical survival and prognosis, lymph node infiltration, as well as invasiveness and metastasis in a variety of tumor types, including breast, lung, melanoma, gastric, ovarian, cervical, and hepatocellular carcinomas [27].